Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.
NA
The SUBMO-PIC01-2025 study evaluates whether SUBMO®, a submucosal injection...
Status
Recruiting
Location
Hospital Universitario de la Santa Creu i Sant Pau
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
PHASE3
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...